Company Research Report: Sim&Cure
Company Overview
- Name: Sim&Cure
- Mission: The company's mission is to improve patient care in brain aneurysm treatment. The company emphasizes creating a warm, nurturing environment where employees feel valued to achieve this mission.
- Founded: 2014
- Founders: No information is available.
- Key People:
- Mathieu Sanchez, PhD - CEO, Co-Founder
- Dan Raffi - Chief Operating Officer
- Christophe Chnafa, PhD - Chief Innovation & Strategy Officer
- Headquarters: 95 rue Pierre Flourens, Bât H34090 Montpellier, France
- Number of Employees: No information is available.
- Revenue: No information is available.
- Notable For: Sim&Cure is known for its innovative software solutions in neurovascular treatment, particularly for brain aneurysms, including the Sim&Size™ software.
Products
- Sim&Size™
- Description: A software product designed to optimize the treatment of brain aneurysms.
- Key Features:
- Certified CE mark Class IIa
- ISO 13485 certified
- 510(k) cleared by the FDA
Recent Developments
- New Appointments: Dan Raffi was appointed as the Chief Operating Officer and Board Member in October 2021.
- Academic Publications: A variety of research papers have been published, showcasing developments and applications of the Sim&Size software in the treatment of intracranial aneurysms and neurovascular procedures.
- New Products or Features: No specific information on new products or features launched.
- Partnerships: The company fosters strong connections with stakeholders as part of its operational strategy, though specific partnership details are not available.
Conclusion
This report focuses on Sim&Cure's operations and its focus on improving neurovascular treatment solutions. Insights into specific revenue figures, employee numbers, and product pricing are not provided; however, the detailed roles of key individuals and locations of operations have been articulated.
This concludes the company-focused market research report on Sim&Cure.
